At doom’s doorstep: It is 100 seconds to midnight

Disruptive Technologies

How evil can prevail in state-sanctioned biowarfare research

By Laura H. Kahn | Biosecurity, Columnists

Raising life scientists’ awareness

By Malcolm Dando | Biosecurity, Columnists

The challenges of developing synthetic pathogens

By Gerald L. Epstein | Biosecurity, Opinion

The furor over genetically modified foods

By Laura H. Kahn | Biosecurity, Columnists

Missed opportunities at the chemical weapons treaty meeting

By Malcolm Dando | Biosecurity, Columnists

Getting scientists involved in arms control

By Malcolm Dando | Biosecurity, Columnists

Improving infectious disease surveillance

By | Biosecurity, Opinion

In pursuit of international biosecurity oversight

By Laura H. Kahn | Biosecurity, Columnists

The potential dangers in medical isotope production

By Laura H. Kahn | Biosecurity, Columnists

Setting the nanotech research agenda

By Andrew Maynard | Biosecurity, Opinion

Helping the United Nations combat bioterrorism

By Barbara Hatch Rosenberg | Biosecurity, Opinion